VIRMA and nasopharyngeal carcinoma: DNA methylation analysis was performed by dividing patients after nasopharyngeal cancer treatment into two groups with good and poor prognosis, and it was found that hypermethylation of VIRMA was associated with poor outcomes in patients with NPC, which can act as a prognostic biomarker for nasopharyngeal carcinoma [45,46].